GGrantIndex
← Leaderboards

Orhan Nalcioglu

University Of California Irvine

$5,072,098
Attributed
$5,072,098
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $910.6K · FY200513
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$5,072,098 · 9

By mechanism

R01$1,905,844 · 1
R33$1,259,567 · 1
P20$1,159,638 · 1
R21$668,282 · 3
P30$78,767 · 3

Top collaborators

No co-investigators on record.

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging

Research focus

Magnetic Resonance ImagingAngiogenesisBioimaging /Biomedical ImagingBreast NeoplasmsClinical ResearchImmunocytochemistryP53 Gene /ProteinNeoplasm /Cancer Relapse /RecurrenceOpticsMetastasisPrognosisVascular Endothelial Growth FactorsAnimalsModalityAnimal ModelBaseMalignant NeoplasmsBreast Neoplasm /Cancer DiagnosisFundingImageAdenoviridaeLaboratory RatDiagnosis Design /EvaluationGadolinium

Grant awards (21)

ONCO-IMAGING & SPECTROSCOPY PROGRAM$12,338
P30 · FY2013 · CA · contact PI
ONCO-IMAGING & SPECTROSCOPY PROGRAM$21,489
P30 · FY2011 · CA · contact PI
ONCO-IMAGING & SPECTROSCOPY PROGRAM$22,702
P30 · FY2010 · CA · contact PI
ONCO-IMAGING & SPECTROSCOPY PROGRAM$22,238
P30 · FY2009 · CA · contact PI
COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING$371,428
R33 · FY2007 · CA · contact PI
COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING$375,000
R33 · FY2006 · CA · contact PI
COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING$513,139
R33 · FY2005 · CA
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER$397,425
R01 · FY2005 · CA
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER$387,760
R01 · FY2004 · CA
COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING$156,922
R21 · FY2004 · CA
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER$378,376
R01 · FY2003 · CA
CENTER FOR IN-VIVO MOLECULAR FUNCTIONAL ONCO-IMAGING$396,242
P20 · FY2002 · CA
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER$369,265
R01 · FY2002 · CA
CORE--ONCO-IMAGING FACILITY$0
P30 · FY2002 · CA
PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER$373,018
R01 · FY2001 · CA
CENTER FOR IN-VIVO MOLECULAR FUNCTIONAL ONCO-IMAGING$363,396
P20 · FY2001 · CA
AN MRI DETECTABLE NEOVASCULAR TARGETED ADENOVIRUS$150,400
R21 · FY2001 · CA
INVESTIGATION OF ANGIOGENIC FUNCTION IN CANCER BY MRI$105,280
R21 · FY2001 · CA
CENTER FOR IN VIVO MOLECULAR FUNCTIONAL ONCO IMAGING$400,000
P20 · FY2000 · CA
AN MRI DETECTABLE NEOVASCULAR TARGETED ADENOVIRUS$150,400
R21 · FY2000 · CA
INVESTIGATION OF ANGIOGENIC FUNCTION IN CANCER BY MRI$105,280
R21 · FY2000 · CA